Free Communications


Please find below the detailed overview of the Free Communication sessions with all the pertinent details.

Free Communications I.

|

Free Communications II.


Free Communications I. - Acute and chronic inflammatory diseases/treatment
Saturday, 4 May 2019; 08:00 - 09:00 (Elafiti I.)

08:00 - 08:10 Hidradenitis suppurativa in Pediatric Population: A multicenter retrospective study of 481 patients – Preliminary results
Irene Lara-Corrales
08:10 - 08:20 Eczema phenotypes and risk of allergic and respiratory conditions in school-age children
Chen Hu
08:20 - 08:30 Early and sustained, clinically meaningful responses with dupilumab treatment in a phase 3 trial in adolescents with moderate-to-severe atopic dermatitis
Amy Paller
08:30 - 08:40 Mycoplasma pneumoniae-induced mucocutaneous disease: A prospective longitudinal cohort study
Martin Theiler
08:40 - 08:50 Anogenital lichen sclerosus in pediatric population of Nort-east part of Hungary
Erzsébet Szakos
08:50 - 09:00 Eosinophilic cellulitis (Wells syndrome) occurring in a three year old boy
Valentina Saint-Georges


Free Communications II. - Genodermatoses
Saturday, 4 May 2019; 08:00 - 09:00 (Elafiti II.)

08:00 - 08:10 Telangiectasia – ectodermal dysplasia. A new disease caused by mutations in PRKD1
Antonio Torrelo
08:10 - 08:20 Are biologics a therapeutic hope for keratinization disorders? Our experience in two patients with SAM syndrome treated with secukinumab? 
Angela Hernandez-Martin
08:20 - 08:30 Post-zygotic MTOR mutations and Ito hypomelanosis: Phenotypic spectrum and ultrastructural characterization
Virginie Carmignac
08:30 - 08:40 Phakomatosis pigmentovascularis spilorosea and speckled lentiginous naevus syndrome are caused by mosaic mutations in gene PTPN11
Satyamaanasa Polubothu
08:40 - 08:50 The Zurich Netherton Syndrome Cohort- Characteristics and Treatment Experience
Isabelle Luchsinger
08:50 - 09:00 Epidermolysis bullosa simplex (EBS) with KLHL24 mutations is associated with dilated cardiomyopathy
Agnes Schwieger-Briel